You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 229 No. 10, September 2, 1974 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cytarabine Treatment of Progressive Multifocal Leukoencephalopathy

Clinical Course and Detection of Virus-Like Particles After Antiviral Chemotherapy

John P. Conomy, MD; N. Shelley Beard, MD; Hiroyuke Matsumoto, MD; Uros Roessmann, MD

JAMA. 1974;229(10):1313-1316.


Abstract

Cytarabine (cytosine arabinoside) was utilized in the treatment of a patient with chronic lymphocytic leukemia who developed symptomatic progressive multifocal leukoencephalopathy (PML) after a 12-year course of lymphoproliferative illness. An immediate and impressive degree of neurologic improvement occurred with the institution of antiviral chemotherapy, but clinical benefit was not sustained and the patient died of his neurologic disorder. On gross examination at postmortem, necrotic changes in the demyelinated areas of the brain were seen. Light and electron microscopic studies showed changes characteristic of PML and virus-like particles abundant in glial cells. Cytarabine may have some influence on the course of the illness, but the quality of therapeutic effect needs further investigation.

(JAMA 229:1313-1316, 1974)



Author Affiliations

From the Department of Medicine, Division of Neurology (Drs. Conomy and Matsumoto), and the Divisions of hematology (Dr. Beard), pathology, and neuropathology (Dr. Roessmann), University Hospitals of Cleveland and Case Western Reserve University Medical School, Cleveland.


Footnotes

Reprint requests to University Hospitals of Cleveland, 2065 Adelbert Rd, Cleveland, OH 44106 (Dr. Conomy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Natalizumab and progressive multifocal leucoencephalopathy
Berger
Ann Rheum Dis 2006;65:iii48-iii53.
ABSTRACT | FULL TEXT  

Angiographic Abnormalities in Progressive Multifocal Leukoencephalopathy: An Explanation Based on Neuropathologic Findings
Kim Nelson et al.
Am. J. Neuroradiol. 1999;20:487-494.
ABSTRACT | FULL TEXT  

Progressive Multifocal Leukoencephalopathy: Immunofluorescent Demonstration of Simian Virus 40 Antigen in CSF Cells and Response to Cytarabine Therapy
Peters et al.
Arch Neurol 1980;37:497-501.
ABSTRACT  

Progressive Multifocal Leukoencephalopathy: A Cause of Visual Loss
Appen et al.
Arch Ophthalmol 1977;95:656-659.
ABSTRACT  

Progressive Multifocal Leukoencephalopathy in Renal Transplant Recipients
McCormick et al.
Arch Intern Med 1976;136:829-834.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.